Allscripts Acquires Oasis Medical Solutions

AllscriptsAllscripts (NASDAQ: MDRX) announced the acquisition of privately-held Oasis Medical Solutions Limited, a London-based Patient Administration System (PAS) and health informatics solution provider. The OasisTM PAS system, developed over 18 years in partnership with numerous NHS trusts, provides flexible, efficient and scalable administrative workflow across all venues of care. By combining the Oasis PAS technology with the Allscripts Sunrise clinical platform, Allscripts will offer a highly competitive, single-source offering for an innovative and advanced electronic patient record solution throughout the United Kingdom.

The Oasis PAS is used extensively across the NHS in more than a dozen NHS trusts and hospitals. Clients include East Sussex Healthcare, Royal Surrey County Hospital Trust, Medway NHS Foundation Trust and Worcestershire Acute Hospitals NHS Trust, among others. Oasis hospital clients average over 500 beds per facility, and the company has distinguished itself for its exclusive focus on PAS solutions for the NHS trusts that are innovative, effective, affordable and flexible.

Allscripts has a proven track record of success for clinical solutions, specifically the Allscripts Sunrise clinical electronic health record for inpatient and outpatient care management. Today, Sunrise is live at Liverpool Heart and Chest Hospital NHS Foundation Trust as well as at Salford Royal NHS Foundation Trust. In addition, Allscripts recently announced the opening of its European headquarters in Manchester, UK, committing additional resources to this important healthcare market.

By combining a leading PAS offering with its advanced clinical solution, Allscripts will provide the UK NHS trusts with the clear long-term advantages of integrated workflow between PAS and clinical solutions and the benefit of one business partner that provides a single-source electronic patient record to improve the efficiency and quality of healthcare delivery.

"The United Kingdom is an important growth market for Allscripts core clinical and PAS solutions," said Richard Berner, President, Allscripts International. "A strong clinical offering combined with a highly regarded PAS provides a complete and proven solution to meet the critical long-term needs of the NHS Trusts. By acquiring Oasis, we believe we have optimised our position in the market and expect to drive significant value from this combination for our clients."

Terms of the acquisition were not disclosed.

About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of HealthTM. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...